Miyata Yoshihiko, Nishida Eisuke
Department of Cell and Developmental Biology, Graduate School of Biostudies, Kyoto University, Kyoto 606-8502, Japan.
Mol Cell Biol. 2004 May;24(9):4065-74. doi: 10.1128/MCB.24.9.4065-4074.2004.
Cdc37 is a kinase-associated molecular chaperone whose function in concert with Hsp90 is essential for many signaling protein kinases. Here, we report that mammalian Cdc37 is a pivotal substrate of CK2 (casein kinase II). Purified Cdc37 was phosphorylated in vitro on a conserved serine residue, Ser13, by CK2. Moreover, Ser13 was the unique phosphorylation site of Cdc37 in vivo. Crucially, the CK2 phosphorylation of Cdc37 on Ser13 was essential for the optimal binding activity of Cdc37 toward various kinases examined, including Raf1, Akt, Aurora-B, Cdk4, Src, MOK, MAK, and MRK. In addition, nonphosphorylatable mutants of Cdc37 significantly suppressed the association of Hsp90 with protein kinases, while the Hsp90-binding activity of the mutants was unchanged. The treatment of cells with a specific CK2 inhibitor suppressed the phosphorylation of Cdc37 in vivo and reduced the levels of Cdc37 target kinases. These results unveil a regulatory mechanism of Cdc37, identify a novel molecular link between CK2 and many crucial protein kinases via Cdc37, and reveal the molecular basis for the ability of CK2 to regulate pleiotropic cellular functions.
Cdc37是一种激酶相关分子伴侣,其与Hsp90协同发挥的功能对许多信号蛋白激酶至关重要。在此,我们报道哺乳动物Cdc37是酪蛋白激酶II(CK2)的关键底物。纯化的Cdc37在体外被CK2磷酸化在一个保守的丝氨酸残基Ser13上。此外,Ser13是Cdc37在体内的唯一磷酸化位点。至关重要的是,Cdc37在Ser13上的CK2磷酸化对于Cdc37与所检测的各种激酶(包括Raf1、Akt、Aurora-B、Cdk4、Src、MOK、MAK和MRK)的最佳结合活性至关重要。此外,Cdc37的不可磷酸化突变体显著抑制了Hsp90与蛋白激酶的结合,而突变体的Hsp90结合活性未改变。用特异性CK2抑制剂处理细胞可抑制Cdc37在体内的磷酸化,并降低Cdc37靶激酶的水平。这些结果揭示了Cdc37的一种调控机制,通过Cdc37确定了CK2与许多关键蛋白激酶之间的一种新的分子联系,并揭示了CK2调节多效性细胞功能能力的分子基础。